Opexa Therapeutics Inc (NASDAQ:OPXA)

0.39
Delayed Data
As of May 22
 +0.0006 / +0.15%
Today’s Change
0.33
Today|||52-Week Range
1.75
-45.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$20.8M

Company Description

Opexa Therapeutics, Inc. engages as a biopharmaceutical company which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. The company was founded in March 1991 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:

Employees

Shareholders

Individual stakeholders6.39%
Mutual fund holders4.04%
Other institutional15.68%

Top Executives

Neil K. WarmaPresident, Chief Executive Officer & Director
Karthik RadhakrishnanChief Financial Officer
Dawn McGuireChief Medical Officer
Donald HealeyChief Scientific Officer
Donna R. RillChief Development Officer

To view my watchlist

Not a member yet?

Sign up now for a free account